Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. (Q53600580)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. |
scientific article |
Statements
Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. (English)
Mamoru Hasegawa
Makoto Inoue
Takaaki Fujii
Yoshikazu Yonemitsu
Mitsuho Onimaru
Mitsugu Tanii
Toshiaki Nakano
Kensuke Egashira
Takako Takehara
Hiroyuki Kuwano
Katsuo Sueishi
7 September 2006
26
11
2483-2489